Extra General Meeting, October 23, 2025, at 2:00 p.m

The shareholders in Umecrine Cognition AB, reg. no. 556698-3655, are hereby given notice to attend an extraordinary general meeting at 2:00 p.m. on Thursday 23 October 2025 at Setterwalls Advokatbyrå’s offices at Sturegatan 10 in Stockholm, Sweden.

The board of directors has decided, pursuant to Chapter 7, Section 4, Paragraph 2 of the Swedish Companies Act and the company’s articles of association, to apply the possibility of proxy collection in conjunction with the extraordinary general meeting (see section Proxy collection below for further information).

Notice

Shareholders wishing to participate at the meeting must:

(i) be entered in the shareholders’ register, kept by Euroclear Sweden AB (the Swedish Central Securities Depository & Clearing Organisation), on the record day which is Wednesday 15 October 2025; and

(ii) notify the company of their attendance and any assistants no later than Friday 17 October 2025. Notification can be made via letter to Setterwalls Advokatbyrå AB, Attn: Niclas Töreki, P.O. Box 1050, SE-101 39 Stockholm, Sweden or by e-mail to [email protected].

Notification shall include full name, personal identification number or corporate registration number, address and daytime telephone number and, where appropriate, information about representative, proxy and assistants. The number of assistants may not be more than two. In order to facilitate entry to the meeting, notification should, where appropriate, be accompanied by powers of attorney, registration certificates and other documents of authority.

Proposed agenda

  1. Opening of the meeting and election of chairman of the meeting;
  2. Preparation and approval of the voting list;
  3. Approval of the agenda;
  4. Election of one or several persons who shall approve the minutes of the meeting;
  5. Determination of whether the meeting has been duly convened;
  6. Resolution on change of company category and adoption of new articles of association;
  7. Election of chairman of the board of directors;
  8. Determination of the fees payable to the members of the board of directors;
  9. Closing of the meeting.